Видео ютуба по тегу Biocon Group Fy24 Business Outlook

Biocon's Kiran Mazumdar Shaw On Strong Q4, Biosimilar Business & FY24 Outlook | Halftime Report

Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn

Biocon Appoints Peter Bains As Group CEO To Drive 'Synergistic' Growth: What's The Road Ahead?

Biocon Set For New Biosimilar Launch

Our acquisition of Viatris business has been 'spooking the Indian investor,' biotechnology firm says

Group Research webinar: Inflation outlook and implication for assets

Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO

Biocon Launches Biosimilar Adalimumab In US Market, Drug Used For Arthritis, Skin Disorders

Counting down to #Biocon’s API customer portal 'BioConnect launch!

Business efficiency: How a small business operates like a corporation

O365 Groups not appearing in Outlook/OneDrive

Biocon Biologies IPO, Debt Reduction Strategy & More | Kiran Mazumdar-Shaw & Peter Bains

Q1 Review: Biocon's Profit, Margins Fall, Misses Estimates | BQ Prime

Serum takes its investment in Biocon Bio to $300 Million, Kiran M Shaw On This & More | CNBC-TV18